Clinical Trial

The Metabolic and Genetic Drivers of Body Composition Changes Following Weight Loss Surgery

Recruiting
View on ClinicalTrials.gov →
Summary
Weight loss surgery is very good at reducing body weight but it can also cause the loss of both muscle and strength. Some patients undergoing weight loss surgery do not achieve their weight loss goals and regain the weight they lost. When this occurs, the loss of muscle and strength combined with the regain of weight can impact the individual's quality of life and ability to remain active and mobile. The purpose of this study is to understand the behavioral, biological, and genetic factors that influence the success of weight loss surgery and its impact on muscle mass. Bariatric surgery patients participating in the trial will be monitored prior to, and for a year following weight loss surgery, with data collected about their eating habits, hand grip strength, and the loss of fat, muscle, and body weight following surgery. In patients who undergo a routine endoscopy in advance of weight loss surgery a small sample of gut tissue will be collected to identify the expression (activity) of genes in their DNA.
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-07-11
minor Trial arms changed: 2 -> 1 2026-07-11
Trial Details
NCT Number NCT07178704
Lead Sponsor The University of Texas Medical Branch, Galveston
Conditions Bariatric Surgery Patients
Enrollment 100 participants
Start Date 2025-11-04
Primary Completion 2027-02 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-10